Heparin Sodium Injection
Heparin Sodium Injection is a sterile, preservative-containing anticoagulant solution intended for intravenous or deep subcutaneous use. Widely used in hospitals and surgical centers, this trusted formulation plays a critical role in preventing and treating various thromboembolic disorders.
Key Benefits:
• Clinically Proven Anticoagulant: Used for the prevention and treatment of venous thrombosis, pulmonary embolism, atrial fibrillation with embolization, and peripheral arterial embolism.
• Surgical Support: Recommended during cardiac and vascular procedures to prevent clotting, as well as for prophylaxis of postoperative deep vein thrombosis.
• Dialysis & Transfusion Compatibility: Effective for maintaining patency in dialysis circuits and preventing coagulation during blood transfusions.
• Flexible Dosage Strengths: Available in multiple vial strengths including 1,000 USP units/mL, 5,000 USP units/mL, and 10,000 USP units/mL to meet diverse clinical needs.
Dosage and Administration:
Heparin Sodium Injection should only be administered under the supervision of trained medical personnel. Dosage is highly individualized and must be guided by coagulation testing.
• Deep Subcutaneous (Intrafat) Injection: Initial IV dose of 5,000 units followed by 10,000 to 20,000 units SC. Maintenance: 8,000–20,000 units every 8 to 12 hours.
• Intermittent Intravenous Injection: Initial dose: 10,000 units; Maintenance: 5,000–10,000 units every 4–6 hours.
• Continuous IV Infusion: 20,000–40,000 units/24 hours diluted in 0.9% Sodium Chloride Injection.
Why Choose Heparin Sodium Injection?
• Established Clinical Efficacy: In use since 1939, Heparin Sodium remains the gold standard anticoagulant for intravenous and subcutaneous use in hospital settings.
• Comprehensive Patient Management: Suitable for emergency, perioperative, and chronic care anticoagulation protocols.
• Trusted by Healthcare Professionals: Manufactured in compliance with FDA standards for safety and efficacy in anticoagulant therapy.
Warnings:
• Not for use as a catheter lock flush.
• Use caution in patients with bleeding disorders, thrombocytopenia, or heparin-induced thrombocytopenia (HIT/HITTS).
• Avoid use in neonates and infants due to benzyl alcohol preservative.
• Monitor coagulation parameters and platelet counts during treatment.
Contraindications:
• Active major bleeding (except in DIC)
• Uncontrolled bleeding tendencies
• History of HIT or HITT
• Hypersensitivity to heparin or pork products
Disclaimer: This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.